Eastman Chemical (NYSE:EMN – Get Free Report) issued an update on its FY24 earnings guidance on Thursday morning. The company provided earnings per share guidance of $7.40-7.85 for the period, compared to the consensus earnings per share estimate of $7.68. Eastman Chemical also updated its FY 2024 guidance to 7.400-7.850 EPS.
Eastman Chemical Trading Up 0.8 %
Shares of EMN traded up $0.77 during trading hours on Thursday, reaching $97.15. 1,136,552 shares of the company traded hands, compared to its average volume of 978,300. The firm has a market cap of $11.43 billion, a price-to-earnings ratio of 12.52, a PEG ratio of 1.07 and a beta of 1.46. Eastman Chemical has a 12-month low of $68.89 and a 12-month high of $105.98. The company has a current ratio of 1.39, a quick ratio of 0.71 and a debt-to-equity ratio of 0.77. The stock’s fifty day moving average price is $98.90 and its 200 day moving average price is $94.26.
Eastman Chemical (NYSE:EMN – Get Free Report) last issued its earnings results on Thursday, April 25th. The basic materials company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.20. The firm had revenue of $2.31 billion during the quarter, compared to analyst estimates of $2.29 billion. Eastman Chemical had a net margin of 10.16% and a return on equity of 13.84%. The business’s revenue was down 4.2% on a year-over-year basis. During the same period in the previous year, the firm earned $1.63 earnings per share. Sell-side analysts forecast that Eastman Chemical will post 7.69 earnings per share for the current year.
Eastman Chemical Dividend Announcement
Wall Street Analyst Weigh In
Several analysts have commented on EMN shares. KeyCorp increased their price target on shares of Eastman Chemical from $101.00 to $121.00 and gave the company an overweight rating in a research report on Tuesday, April 9th. Mizuho raised their price target on shares of Eastman Chemical from $91.00 to $102.00 and gave the stock a neutral rating in a research report on Friday, April 26th. Wells Fargo & Company lifted their target price on shares of Eastman Chemical from $89.00 to $100.00 and gave the company an equal weight rating in a report on Thursday, April 11th. Royal Bank of Canada lifted their price target on shares of Eastman Chemical from $100.00 to $104.00 and gave the company a sector perform rating in a research note on Tuesday, April 30th. Finally, UBS Group raised shares of Eastman Chemical from a neutral rating to a buy rating and lifted their price target for the company from $106.00 to $128.00 in a research note on Thursday, May 23rd. Seven equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of Moderate Buy and a consensus price target of $107.31.
Read Our Latest Report on Eastman Chemical
Insider Activity at Eastman Chemical
In other Eastman Chemical news, SVP Adrian James Holt sold 1,975 shares of the business’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $99.22, for a total transaction of $195,959.50. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, CEO Mark J. Costa sold 102,390 shares of the business’s stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $100.78, for a total transaction of $10,318,864.20. Following the completion of the transaction, the chief executive officer now directly owns 395,699 shares of the company’s stock, valued at $39,878,545.22. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Adrian James Holt sold 1,975 shares of the business’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $99.22, for a total value of $195,959.50. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 108,027 shares of company stock worth $10,885,638. Company insiders own 1.93% of the company’s stock.
Eastman Chemical Company Profile
Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.
Read More
- Five stocks we like better than Eastman Chemical
- CD Calculator: Certificate of Deposit Calculator
- Viking Therapeutics: Pharma Stock Soars on Positive Earnings
- Comparing and Trading High PE Ratio Stocks
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- Manufacturing Stocks Investing
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.